Sep 18 |
GSK (LSE:GSK) Poised for Growth with Strong Sales, Strategic Alliances, and New Vaccine Launches
|
Sep 18 |
GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX
|
Sep 16 |
Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk
|
Sep 14 |
GSK, iTeos lung cancer therapy outperforms Jemperli in mid-stage trial
|
Sep 13 |
BioNTech (BNTX) Stock Jumps 5.8%: Will It Continue to Soar?
|
Sep 13 |
Top fund picks for self-invested pensions
|
Sep 12 |
Gilead Stock Rises on Positive Study Results for Twice-Yearly HIV Drug
|
Sep 12 |
GSK, CureVac mRNA flu shot reaches late-stage studies
|
Sep 12 |
Fulcrum crashes as GSK-partnered lead program fails
|
Sep 11 |
GSK reaches settlement in Illinois Zantac case
|